Table 2. Fatty acid profile.
| Patients | PKU n = 43 | Controls n = 58 | p-value |
|---|---|---|---|
| Omega-3 fatty acids, amount % | 8.22 ± 0.24 | 8.41 ± 0.22 | 0.52 |
| α-Linolenic acid (ALA), 18:3 | 0.20 ± 0.03 | 0.19 ± 0.02 | 0.995 |
| Eicosapentaenoic acid (EPA), 20:5 | 0.59 ± 0.04 | 0.62 ± 0.04 | 0.686 |
| Docosapentapentaenoic acid (DPA), 22:5 | 1.98 ± 0.14 | 1.95 ± 0.12 | 0.816 |
| Dococohexaenoic acid (DHA), 22:6 | 4.20 ± 0.15 | 4.50 ± 0.17 | 0.167 |
| Omega-6 fatty acids, amount % | 26.39 ± 1.29 | 26.61 ± 1.08 | 0.94 |
| Dihomo-gamma-linoleic acid, 20:3 | 1.42 ± 0.08 | 1.34 ± 0.07 | 0.331 |
| Arachidonic acid, 20:4 | 11.43 ± 0.64 | 11.38 ± 0.07 | 0.959 |
| Omega-3/omega-6 fatty acid ratio | 1:3.3 ± 0.19 | 1:3.26 ± 0.17 | 0.54 |
Results are shown as mean ± SEM; p value of < 0.05 was regarded as significant *.
Fatty acid profile were measured in red cell membranes.